GlaxosmithKline Pharmaceuticals informs about certificate

05 Apr 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxosmithKline Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from Kfintech, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2021.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2588.00 -36.85 (-1.40%)
27-Feb-2026 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1761.00
Dr. Reddys Lab 1287.00
Cipla 1345.10
Zydus Lifesciences 924.60
Lupin 2328.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×